Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001628280-26-026014

10% owner acquired 759,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Frankenius Equity AB 10% owner 2025-07-31 Conversion +759,000 6,989,748 D
Derivatives
Frankenius Equity AB 10% owner 2025-07-31 Conversion · Series A Convertible Preferred Stock −230,000 0 D
Loading xslF345X06/wk-form4_1776717403.xml…